China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million 2025-01-07T03:51:29-05:00January 7th, 2025| share this article![#item_full_content] Read More share this article! Related Posts Dyna-Mac delists from SGX on Jan 9 January 9th, 2025 SoftBank and Arm weigh acquiring Ampere Computing, Bloomberg reports January 9th, 2025 Stocks to watch: Suntec Reit, China Everbright Water, Tan Chong International January 9th, 2025 Seven & i convenience store recovery hits wider retail headwinds January 9th, 2025
